Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…
Read More
MSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic Diversification
The pharmaceutical landscape has been significantly reshaped with MSD (Merck & Co.) achieving a monumental victory: the US Food and…
Read MoreYOU MAY HAVE MISSED
